France’s BPCE has agreed a 6.4 billion euros ($7.39 billion) deal to acquire Portugal's Novo Banco, including a 75% stake held by U.S. private equity firm Lone Star, BPCE and Lone Star said on Friday.

LISBON (Reuters) -U.S. private equity fund Lone Star has decided to sell its 75% stake in Novo Banco to French banking group BPCE in a deal that would value Portugal's fourth-largest lender at ...

Novo Banco spun out of the collapsed Banco Espirito Santo (BES) in 2014 after a state bailout. US investor Lone Star, which bought its stake in Novo Banco in 2017, is now offloading it.

LISBON (Reuters) -U.S. private equity fund Lone Star has decided to sell its 75% stake in Novo Banco to French banking group BPCE in a deal that would value Portugal's fourth-largest lender at around ...

Groupe BPCE agreed to buy Novo Banco from majority owner Lone Star in the latest cross-border European banking deal, which values the Portuguese lender at 6.4 billion euros ($7.41 billion).

In the latest of a series of cross-border merger dramas, France’s BPCE is acquiring a 75% stake in Portugal’s Novo Banco from US private equity firm Lone Star. The offer values the lender at €6.4bn, ...

Groupe BPCE has entered a deal to acquire Portuguese lender Novo Banco, valuing the business at €6.4bn ($7.4bn). The deal will see the French bank purchasing a 75% stake in Novo Banco from Lone ...

NOVO BANCO S.A. (XS0972653132) - All master data, key figures and real-time diagram.

The Banco Espírito Santo S.A.-Bond has a maturity date of 1/2/2043 and offers a coupon of 3.5000%. The payment of the coupon will take place 1,0 times per Year on the 02.01.. At the current price ...

Novo Nordisk is expanding access to its drug Wegovy through a new partnership with WeightWatchers, days after cutting ties with telehealth firm Hims & Hers. Starting July 1, WeightWatchers will ...

Novo Nordisk (NYSE: NVO) is one of the most active stocks to buy according to analysts. On June 20, Novo Nordisk announced that its investigational obesity treatment, amycretin, will advance ...